Fixing the ImpossiBle
24/7 (202) 973-1300   

Tony Haight, PhD, Distinguished Research Fellow, Novel Therapeutic Platforms on Testing Promising Drugs

Tony Haight, PhD Distinguished Research Fellow, Novel Therapeutic Platforms and a consultant to the Children’s Cancer Therapy Development Institute (cc-TDI) speaks with host Richard Levick of LEVICK about the process of testing promising drugs, how it succeeds and how it fails and about his work on children’s cancer therapies, an area of medicine which lags far behind the adult versions of the disease. Currently, Dr Haight leads the Emerging Therapeutics Platform Organization in Development Sciences focused on cross-functional efforts for learnings – in such areas as antibody drug conjugates, targeted degradation, and targeted delivery.  Dr Haight received his PhD in Chemistry from the University of Wisconsin-Madison.  He has presented his research, authored, or coauthored more than 25 articles and is inventor or co-inventor on more than 50 patents or patent applications. Listen here